Cost-Effectiveness Analysis Of Ambrisentan Versus Bosentan In The Treatment Of Patients With Pulmonary Arterial Hypertension Functional Class III
May 1, 2014, 00:00
10.1016/j.jval.2014.03.682
https://www.valueinhealthjournal.com/article/S1098-3015(14)00733-5/fulltext
Title :
Cost-Effectiveness Analysis Of Ambrisentan Versus Bosentan In The Treatment Of Patients With Pulmonary Arterial Hypertension Functional Class III
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00733-5&doi=10.1016/j.jval.2014.03.682
First page :
A117
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
116